Allergy Submission Guide: Requirements & Editorial Fit
Allergy submission guide: allergy and immunology research with mechanistic depth and clinical-translation pathway.
Readiness scan
Find out if this manuscript is ready to submit.
Run the Free Readiness Scan before you submit. Catch the issues editors reject on first read.
How to approach Allergy
Use the submission guide like a working checklist. The goal is to make fit, package completeness, and cover-letter framing obvious before you open the portal.
Stage | What to check |
|---|---|
1. Scope | Define the allergic-disease use case |
2. Package | Clarify clinical versus mechanistic contribution |
3. Cover letter | Stress patient or practice relevance |
4. Final check | Position against nearby allergy journals |
Quick answer: submit to Allergy only if the manuscript is clinical, translational, or mechanistically relevant to allergic disease. Wiley portal mechanics matter, but the decisive screen is fit: the editor should see allergy-specific relevance in the title, abstract, study design, and first results, not only in the discussion.
Editorial detail (for desk-screen calibration). Allergy is the official journal of the European Academy of Allergy and Clinical Immunology (EAACI) and uses Wiley's ScholarOne manuscript portal at mc.manuscriptcentral.com/all rather than the public Wiley Online Library URL. The intake flow has six structured sections (manuscript type, authors and institutions, abstract and keywords, file upload, review preferences, validation) and Wiley flags incomplete sections immediately. Original Research articles cap at 4,000 words (excluding references and supplementary), structured abstracts cap at 250 words (background, methods, results, conclusions), 4 to 6 keywords required, ORCID required for corresponding author, figures at 300 DPI minimum, and a Word document with embedded figures is the preferred initial-submission format. Across our pre-submission reviews of Allergy manuscripts, the editorial triage pattern is fast and structurally biased toward translational immunology: roughly 30 to 40 percent of submissions are desk-rejected at editorial screening within 1 to 2 weeks, and the dominant failure pattern is animal-model or mechanism-only work without translational components built into the study design. Editors routinely reject papers where translational implications are added in the discussion rather than embedded in the experimental design (the test: would the experiments need to change if you removed the translational framing?), where the work is purely clinical without an immunological mechanism layer that would interest the EAACI readership, where the scope is allergy-adjacent rather than allergy-central (general inflammation, general autoimmunity, general respiratory), where EAACI Congress 2026 abstract submissions are misformatted as full research articles, or where the cover letter does not name the clinical-allergy practice the work would change. The editorial culture rewards papers that pair human-relevant data with mechanism work in the same package; it filters out single-tier work that leans entirely on bench or entirely on clinical.
From our manuscript review practice
Of manuscripts we've reviewed for Allergy, animal model papers without translational components in the experimental design is the most consistent desk-rejection trigger. Adding translational implications to the discussion does not satisfy this requirement; the translational component must be built into the study design itself.
What official pages do not answer
Official Wiley or EAACI pages answer the formal questions: journal identity, Wiley submission support, article preparation, file handling, title-page separation, peer-review confidentiality, and status labels. Those pages are useful, but they do not answer the harder author question before upload: whether the manuscript is truly an Allergy paper rather than a broader immunology, respiratory, dermatology, or translational-medicine paper.
This guide separates translating the journal's clinical-allergy scope into editorial screen logic. Official guidance does not tell you whether the first page proves allergy-specific relevance, whether the translational claim is built into the design, or whether the cover letter is carrying a fit argument the manuscript should already make.
How this page was created: we checked EAACI's Allergy journal profile, Wiley author-services submission guidance, the Wiley Online Library journal page, public review-time reports, and Manusights review patterns from allergy and clinical-immunology submissions.
Source limitations: we did not submit a private test manuscript through Allergy's ScholarOne workflow. Wiley portal screens and required fields can change, so use the official author instructions for final upload mechanics.
This guide tells you what Allergy editors look for before review. The review tells you whether YOUR paper passes that first-read screen. Manusights has reviewed manuscripts targeting Allergy and nearby allergy or immunology journals, uses zero-retention manuscript processing, and we do not train models on your manuscript. Paid reports include a money-back guarantee on report delivery quality.
This Allergy submission guide walks through what you actually need to check before submitting, from scope verification to portal setup. The point is not just to clear the technical upload steps but to make sure the manuscript reads like a paper the editors would want to send to review.
Allergy Journal Scope and Article Types
Allergy focuses on clinical and translational research in allergic diseases, asthma, and immunology. They want papers that advance understanding of allergic mechanisms or improve patient care.
- Original research articles form the core content. Clinical studies examining new treatments, diagnostic approaches, or disease mechanisms get priority. Basic science papers need clear clinical relevance. Population studies and epidemiological research that inform clinical practice also fit well.
- Clinical trials require CONSORT reporting guidelines. Phase II and III trials get preference over early-phase studies. Real-world evidence studies and pragmatic trials align with the journal's clinical focus.
- Reviews and meta-analyses should synthesize recent advances or controversial topics in allergy practice. Systematic reviews following PRISMA guidelines work better than narrative reviews. The editors want reviews that help clinicians make decisions, not just summarize literature.
- Brief communications report preliminary findings or novel observations. These run under 1,500 words and need immediate clinical relevance. Case series with new insights about rare allergic conditions sometimes work here.
- Letters to the editor respond to published articles or report interesting cases. Keep these under 500 words with one figure maximum.
The journal won't consider basic immunology papers without clear allergy connections. Food chemistry studies without clinical endpoints don't fit. Animal model papers need strong translational components to get past desk review.
Step-by-Step Submission Process
Allergy uses Wiley's ScholarOne manuscript submission system. You'll need to create an account if you don't have one already. The portal handles submissions for multiple Wiley journals, so your login works across their platform.
- Before you start uploading: Prepare your cover letter first. You'll paste this into a text box during submission, not upload it as a file. Have your manuscript saved as a Word document with figures embedded at appropriate locations. Separate high-resolution figure files aren't required at initial submission but help during production if accepted.
- ScholarOne submission steps: Log into ScholarOne and select "Author Center." Click "Submit a New Manuscript" and choose Allergy from the journal list. The system walks through six main sections.
- Manuscript type and details: Select your article type from the dropdown menu. Original Article covers most research papers. Enter your title exactly as it appears in your manuscript. The system generates a manuscript ID that you'll use for all correspondence.
- Authors and institutions: Add all authors in order. Include full names, affiliations, and email addresses. Designate one corresponding author who'll receive all editorial communications. The system requires ORCID IDs for corresponding authors.
- Abstract and keywords: Paste your structured abstract into the text box. Select 4-6 keywords from the provided list. The system suggests keywords based on your abstract content. Choose terms that match your research focus precisely.
- File upload: Upload your main manuscript file first. The system accepts Word documents and PDFs, but Word works better for editorial review. Upload figures as separate files if they're not embedded in the manuscript. Tables can stay in the main document.
- Review preferences: You can suggest reviewers or request to exclude specific individuals. Provide brief justifications for your suggestions. The editors appreciate good reviewer suggestions but aren't bound by them.
- Final validation: Review all entered information before submission. The system flags missing required fields. Once submitted, you can't modify the manuscript without editorial permission.
The system sends a confirmation email with your manuscript ID within minutes. Use this ID for all future correspondence about your submission.
Formatting Requirements and Common Mistakes
Original articles can't exceed 4,000 words excluding references, figure legends, and supplementary material. Count everything from the introduction through discussion. The system flags overlong manuscripts during submission.
- Manuscript structure follows standard format: Title page includes full title, all authors with affiliations, corresponding author contact details, and word count. Don't put acknowledgments or funding information on the title page.
Abstract stays under 250 words with clear background, methods, results, and conclusions sections. Avoid citations in abstracts except for methodology papers referencing established protocols.
Main text uses standard headings: Introduction, Methods, Results, Discussion. Combine Results and Discussion if it improves flow. Methods should include enough detail for replication without excessive length.
- Reference formatting follows standard citation style: Journal articles: Author(s). Title. Journal Year; Volume: pages. Include DOI when available. Book chapters need editor names, book titles, publisher, and page ranges. Web sources require access dates.
- Figure requirements: Submit figures at 300 DPI minimum resolution. JPEG works for photographs, TIFF for line drawings. Label panels as A, B, C in order of appearance. Figure legends go in the main manuscript file, not as separate captions.
- Common formatting mistakes that trigger desk rejection: Exceeding word limits gets automatic rejection. Missing ethics statements for human or animal studies stops review immediately. Incomplete author information or missing conflict of interest declarations also cause delays.
Poor figure quality forces editorial rejection before peer review. Blurry images, pixelated graphs, or unreadable text labels won't work. The production team can't fix fundamental image problems.
Reference formatting errors slow review but don't usually cause rejection. Still, clean references suggest attention to detail that editors notice.
Cover Letter Template for Allergy
Your cover letter should explain why Allergy is the right venue for your research and highlight your main findings without repeating the abstract.
- Opening paragraph: State your manuscript title and article type. Mention why your research fits Allergy's scope specifically.
"We submit our original research article 'Novel biomarkers predict asthma exacerbations in children' for consideration by Allergy. This prospective cohort study identifies serum proteins that predict severe exacerbations 30 days before symptom onset, directly addressing Allergy's focus on clinically relevant biomarker research."
- Main findings paragraph: Highlight your most important results without copying abstract language. Focus on clinical implications and novel contributions.
- Methodology confidence: Briefly mention study design strengths, sample size justification, or statistical approaches that ensure result validity. Don't repeat detailed methods here.
- Significance statement: Explain how your findings advance allergy practice or understanding. Be specific about clinical applications or research directions your work enables.
- Closing: Confirm all authors approve submission and have no competing interests that weren't disclosed. State that the work hasn't been published elsewhere and isn't under review at other journals.
Keep the entire letter under 300 words. Editors read hundreds of cover letters monthly. Clear, direct language works better than elaborate descriptions. For detailed cover letter examples and templates, see our Journal Cover Letter Template: 5 Filled-In Examples for Any Journal (2026).
Review Timeline and What to Expect
Initial editorial screening takes 1-2 weeks. The editors check scope fit, formatting compliance, and basic scientific soundness. About 30-40% of submissions get desk rejected at this stage for scope mismatches or insufficient clinical relevance.
Manuscripts that pass initial screening go to peer review. The editorial office invites 2-3 reviewers per paper. Reviewer response times vary, but the system sends automatic reminders after two weeks.
- Typical timeline breakdown: Week 1-2: Editorial screening and reviewer invitations
Week 3-8: Peer review period
Week 9-12: Editorial decision compilation and communication
Some manuscripts get decisions faster when reviewers respond quickly or when rejection seems clear. Complex papers or those requiring additional editorial consultation can take longer.
- Decision types you might receive: Accept without revision (rare, maybe 5% of accepted papers). Minor revision requiring small changes and author responses to reviewer comments. Major revision needing additional experiments or substantial manuscript changes. Reject with encouragement to submit elsewhere.
The editorial office sends detailed reviewer comments with all decisions except outright rejections. Response letters should address every reviewer concern systematically, even when you disagree with specific points.
Revised manuscripts typically get expedited review, often returning to the same reviewers. Second-round decisions usually come within 4-6 weeks of resubmission.
Acceptance Rate and Editorial Decision Process
Allergy accepts approximately 25-30% of submitted manuscripts, though this varies significantly by article type. Original research articles face the most competition. Review articles have slightly higher acceptance rates when they address timely topics.
- Editorial screening focuses on scope alignment first. Papers studying non-allergic conditions or basic immunology without clear clinical connections get rejected quickly. The editors want research that advances understanding of allergic diseases or improves patient outcomes.
- Scientific quality assessment comes second. Inadequate sample sizes, flawed statistical analyses, or overclaimed conclusions trigger rejection. Clinical studies without proper controls or population studies with selection bias don't pass editorial review.
- Novelty and significance influence final decisions. Incremental findings that confirm known relationships struggle for acceptance. Papers reporting new mechanisms, novel therapeutic approaches, or important negative results get more consideration.
- Common reasons for desk rejection: Scope mismatch represents the biggest category. Studies of general respiratory conditions, infectious diseases, or basic immunology without allergy connections don't fit. Animal model papers lacking translational components also get rejected.
Methodological flaws that can't be fixed in revision lead to rejection. Retrospective studies with inadequate controls, clinical trials without proper randomization, or laboratory studies with insufficient sample sizes won't get peer review.
Poor presentation quality suggests deeper problems. Manuscripts with unclear objectives, disorganized methods sections, or results that don't support conclusions get rejected before peer review.
The editors appreciate well-designed studies that address clinically important questions in allergy practice. Papers that help clinicians make better decisions or reveal new therapeutic targets have the best acceptance chances.
Before you upload, run your manuscript through an Allergy submission readiness check to catch the issues editors filter for on first read.
Readiness check
Run the scan against the requirements while they're in front of you.
See score, top issues, and journal-fit signals before you submit.
Submit If
- Your paper directly investigates an allergic disease mechanism, treatment, or clinical outcome
- The study design includes appropriate controls and sufficient sample sizes for the claims made
- Translational relevance to patient care or clinical practice is explicit in the results, not just the discussion
- Clinical studies include CONSORT or STROBE reporting as appropriate
Think Twice If
- The abstract names allergy, asthma, atopy, or immunotherapy, but the first figure still looks like general immunology without an allergic-disease phenotype
- The allergy connection is primarily in the framing rather than the experimental design, patient samples, clinical endpoints, or phenotype definitions
- Sample sizes, subgroup definitions, or outcome measures are too thin to support the clinical generalizability claimed in the title or conclusion
- The cover letter would need to explain why this is Allergy rather than a broader immunology, respiratory medicine, dermatology, or translational-medicine submission
Allergy pre-submission checklist
- [ ] The title and abstract name the allergic disease, patient population, mechanism, treatment, or clinical decision the paper advances.
- [ ] The first results figure proves allergy-specific relevance, not only immune activation or inflammation in a general system.
- [ ] Human, animal, or in vitro work connects to patient phenotype, clinical endpoint, or allergic-disease mechanism before the discussion section.
- [ ] Ethics approval, consent language, trial registration, reporting guideline use, and conflict-of-interest statements are complete before upload.
- [ ] The cover letter explains why Allergy is the right Wiley and EAACI journal instead of Clinical and Translational Allergy, Pediatric Allergy and Immunology, JACI, or a broader immunology title.
Fast editorial screen table
Stage | Timeline | Requirement |
|---|---|---|
Initial editorial screening | 1-2 weeks | Scope fit, formatting, ethics statements |
Peer review assignment | Weeks 2-3 | Scope passes; 2-3 reviewers invited |
First decision | Weeks 9-12 | Reviewer reports compiled; editorial decision issued |
Revised manuscript review | 4-6 weeks after resubmission | Often returns to same reviewers |
In our pre-submission review work with manuscripts targeting Allergy
In our pre-submission review work with manuscripts targeting Allergy, three issues consistently trigger desk rejection among the papers we analyze.
Manusights pre-submission pattern analysis shows many desk rejections at Allergy trace to scope or framing problems that prevent the paper from competing in this venue. The same pattern analysis often finds these cases involve insufficient methodological rigor or missing validation evidence. A related pattern is that these cases often arise from a novelty claim that outpaces the supporting data.
Animal model papers without translational components
Allergy's editorial guidelines state that animal model papers need strong translational components to clear desk review. We see consistent desk rejection of mouse allergy model papers where the study demonstrates a mechanism but makes no attempt to connect it to human allergy pathology, patient samples, or clinical observations. Adding a paragraph to the discussion about "implications for human disease" does not satisfy this requirement. The translational component needs to be in the experimental design itself, such as validation in patient samples or alignment with documented clinical phenotypes.
Check if your translational design is built into the manuscript →
Clinical studies without allergy-specific scope rationale
We observe that manuscripts studying respiratory disease, skin conditions, or immune responses are frequently desk-rejected when the connection to allergic disease specifically is asserted rather than demonstrated. Allergy is a specialist journal for allergic diseases, asthma, and clinical immunology. A study of airway inflammation that does not demonstrate it is studying allergic airway inflammation will be redirected to a broader respiratory medicine journal. The cover letter needs to explain the allergy-specific contribution explicitly.
Check whether your allergy-specific scope is clear →
Systematic reviews that summarize without advancing clinical practice
Allergy accepts systematic reviews that help clinicians make decisions, not reviews that only summarize existing literature. We find that reviews with comprehensive literature coverage but no actionable clinical synthesis are consistently desk-rejected. The editorial preference is for reviews that identify practice-changing evidence, unresolved clinical questions, or conflicting data that requires synthesis. A review that agrees with current practice guidelines without adding new synthesis rarely clears the initial screen.
Check whether your review adds a clinical decision layer →
Clarivate JCR 2024 bibliometric data provides additional benchmarks when evaluating journal fit.
SciRev author-reported data confirms Allergy's approximately 9-to-12-week median to first decision for papers that enter full peer review. A Allergy submission readiness check can identify scope gaps and translational weaknesses before you open ScholarOne.
Additional pre-submission review patterns for Allergy
In our pre-submission review work on Allergy-targeted manuscripts, three patterns consistently predict desk-screen failure at Allergy (Wiley/EAACI). The patterns below are the same ones the editorial team and outside reviewers flag at first-pass triage.
Scope-fit ambiguity in the abstract. Allergy editors move fastest on manuscripts whose contribution is obviously aligned with allergy and immunology research with mechanistic depth and clinical-translation pathway. The named failure pattern: mechanism-only allergy papers without clinical-translation pathway extend revision rounds. Check whether your abstract reads to Allergy's scope
Methods package incomplete for the journal's reviewer pool. Allergy reviewers expect specific methodological detail. Clinical observational studies without immunological underpinning extend reviewer consultation. Check if your methods package is reviewer-complete
Reference-list and clean-citation failure mode. Editorial team at Allergy (Wiley/EAACI) screens reference lists for retracted-paper inclusion. Check whether your reference list is clean against Crossref + Retraction Watch
Guide-build evidence signal for Allergy (Wiley/EAACI). Our review of public author guidance, recent published article packages, and Manusights pre-submission review patterns points to this practical risk: Allergy reviewers expect both immunological mechanism depth and explicit clinical-translation framing; mechanism-only or clinical-only papers extend revision. Treat this as a fit-and-artifact screen rather than a private outcome claim; official journal pages remain authoritative for submission mechanics and policy requirements.
Related status guide
If your manuscript is already in the portal, use the Allergy Under Review status guide to interpret the status window, follow-up threshold, and reviewer-risk preparation while you wait.
Frequently asked questions
Allergy uses Wiley's ScholarOne manuscript submission system. Create an account, select 'Submit a New Manuscript,' choose Allergy from the journal list, and complete six sections: manuscript type, authors and institutions, abstract and keywords, file upload, review preferences, and final validation. A Word document with embedded figures is preferred for initial submission.
Original articles cannot exceed 4,000 words (excluding references, figure legends, and supplementary material). Abstracts must be under 250 words with structured sections (background, methods, results, conclusions). Figures require 300 DPI minimum resolution. ORCID IDs are required for corresponding authors, and 4-6 keywords must be selected.
Initial editorial screening takes 1-2 weeks. Peer review typically runs 3-8 weeks after screening, with editorial decisions compiled by weeks 9-12. Revised manuscripts usually receive second-round decisions within 4-6 weeks. About 30-40% of submissions are desk-rejected at the screening stage.
Allergy accepts approximately 25-30% of submitted manuscripts, though this varies by article type. Original research articles face the most competition. Review articles addressing timely topics have slightly higher acceptance rates. Scope mismatch is the most common reason for desk rejection.
Sources
- 1. Allergy journal homepage, Wiley.
- 2. Allergy ScholarOne submission portal, Wiley.
- 3. Allergy author guidelines and policies, Wiley.
- 4. Allergy Open Access fees and Wiley OnlineOpen, Wiley.
- 5. Wiley author services, Wiley.
- 6. SciRev author-reported review time data for Allergy, SciRev.
- 7. Clarivate Journal Citation Reports (JCR 2024), Clarivate Analytics.
Before you upload
Choose the next useful decision step first.
Move from this article into the next decision-support step. The scan works best once the journal and submission plan are clearer.
Use the scan once the manuscript and target journal are concrete enough to evaluate.
Anthropic Privacy Partner. Zero-retention manuscript processing.
Where to go next
Same journal, next question
Supporting reads
Conversion step
Choose the next useful decision step first.
Use the scan once the manuscript and target journal are concrete enough to evaluate.